Antimicrobial Susceptibility - Streptococcus pneumoniae
Also known as: MA SPN
Use
This test is utilized to determine the in vitro susceptibility of Streptococcus pneumoniae to a selection of antimicrobial agents. Accurate susceptibility results can guide therapeutic decisions and help in the management of infections caused by this organism, ensuring effective treatment and mitigating the risk of resistance development. Streptococcus pneumoniae is a significant pathogen responsible for various infections, and appropriate antimicrobial therapy is crucial for patient outcomes.
Special Instructions
Not provided.
Limitations
Susceptibility testing is performed by broth microdilution using custom-made MIC panels and interpreted according to CLSI guidelines. However, results should be interpreted in conjunction with the patient's clinical presentation, and it is important to consider that susceptibility may vary based on specific bacterial strains and their unique resistance mechanisms. Mixed cultures or non-viable organisms will lead to unacceptable results and potential rejection of the specimen.
New York Approved
Methodology
Culture-based
Biomarkers
Streptococcus pneumoniae
Microorganism
LOINC Codes
- 29576-6 - Bacterial Susc Pnl Islt
Result Turnaround Time
2-4 days
Related Documents
For more information, please review the documents below
Specimen
Cultured Cells
Volume
Not provided
Minimum Volume
Not provided
Container
sealed container with pure culture on agar slant
Collection Instructions
Transport in a sealed container with pure culture on agar slant. Place each specimen in an individually sealed bag. Ensure that the isolate identification and specimen source are included.
Patient Preparation
Collect actively growing isolate in pure culture.
Storage Instructions
Transport at room temperature.
Causes for Rejection
Mixed cultures or non-viable organisms.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | Unacceptable |
| Frozen | Unacceptable |